Cerenome CNSY
NASDAQ CNSY
$1.60 -0.18 (-10.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cerenome (CNSY) Non-Current Deffered Revenue (2017 - 2023)

Updated

Cerenome (CNSY) recorded Non-Current Deffered Revenue of $1.92 million in Q4 2023, up 17.1% from $1.64 million a year earlier.

Analysis

Cerenome (CNSY) Non-Current Deffered Revenue (2017 - 2023) Analysis & Trends

Starting with Q4 2017, Cerenome's Non-Current Deffered Revenue history includes 6 quarters.

  • Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of 63.0% (FY2018 to FY2023).
  • Across earlier years, Non-Current Deffered Revenue came in at $1.64 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Cerenome 13.01 Mn -34.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.92 Mn
Dec 31, 2022 1.64 Mn
Mar 31, 2019 142,000.00
Dec 31, 2018 167,000.00
Sep 30, 2018 187,000.00
Dec 31, 2017 94,000.00
API Access

Cerenome Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CNSY&period=max&api_key=YOUR_API_KEY